THE PATTERN
EDITION 217 · Thursday 1 October 2026
5 SIGNALS
← 09-30 10-02 → Archive
Edition 217 · Thursday 1 October 2026 · The Pattern

The body becomes the next premium subscription product

Brand & BusinessTech & DigitalFashion & StyleArt & PhotographyCulture & IdeasMusic & Entertainment
PREVENTATIVE
Brand & Business · The Lead
The lead story

Preventative health scanning is becoming a category, not a company

Neko Health, Function Health, and now Midjourney are all converging on the same thesis: the body is an asset that requires regular auditing, and people with money will pay for that service on a recurring basis. This is not wellness. Wellness sells feeling better. This sells knowing more, and the status premium belongs to those who know first. The subscription model migrating from software to biological data is the most consequential consumer behaviour shift happening right now, because it reframes health from a crisis response into a continuous performance metric.

TechCrunch
Read source →
Five signals worth knowing
5 of 25 detected
The Pattern · today's connecting thread

Data about bodies becomes the premium product class

Three stories today point to a single structural shift: the monetisation of personal data is moving from behavioural tracking to biological surveillance, and people are paying willingly. Neko Health, Function Health, and Midjourney's body scanner are all selling the same thing, access to information about yourself that you did not previously have, at a price point that signals status. Meanwhile the OpenAI data extraction story reveals the inverse: institutions are having data taken from them covertly, while individuals are paying premium prices to have data taken from them with full consent.

The dividing line in the next data economy is not privacy versus transparency. It is agency. Who controls the extraction, and who profits from it.

Mike Litman Curator · The Pattern
The Dissent
The breathless framing around preventative health scanning as a status product misses one structural problem: these businesses are selling confidence, not cures, and the regulatory environment for medical-adjacent consumer devices is tightening on both sides of the Atlantic. Neko Health's seven hundred million dollar raise buys a lot of scanners, but the moment a false negative generates a liability claim, the subscription model faces a reckoning that no amount of Silicon Valley branding survives. The comparison to software subscriptions holds only if the product never fails consequentially, and bodies, unlike software, do not release patches.
We Predict
Paramount-Warner Bros. Discovery will announce a major consumer brand licensing deal, explicitly modelled on the Barbie playbook, before end of Q2 2027.
Confidence: 70%
Within By end of Q2 2027
Ynon Kreiz's appointment as co-CEO is the mechanism. He ran exactly this playbook at Mattel: identify dormant IP, build a cultural moment around it, licence outwards rather than produce inwards. The merged entity has enormous IP reserves across both Paramount and Warner catalogues. Kreiz would have no reason to take this role if not to execute the same strategy at scale. The alternative hypothesis is that Ellison's content-first vision dominates and Kreiz's role stays internal. That would have to be true for this to miss, and the public framing of the hire suggests division of responsibility, not subordination.
One to Watch
Ynon Kreiz: the Barbie architect now runs media
Kreiz's appointment as co-CEO of the Paramount and Warner Bros. Discovery merger entity is the most consequential executive hire in entertainment this year. He rebuilt Mattel not by making better toys but by turning IP into cultural infrastructure, and the Barbie film was the proof of concept at scale. The merged entity has more untapped IP than any organisation outside Disney. Watch which properties he moves on first, and watch which brand partners he brings into the room.
If preventative body scanning becomes a status subscription, does your brand have a role in that identity or does it get left behind?
Kreiz turned Mattel's IP into Barbie. Which dormant Paramount or Warner asset does he build the next cultural moment around?
Acne Studios is refusing nostalgia at thirty. Does your brand have the confidence to do the same at its next milestone, or will the archive win?

For people who’d rather be early and wrong than late and safe.

Mike Litman
Curator and Editor
Before it's obvious.
Daily culture intelligence · Free · No noise
𝕏 in